Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma

Annals of Internal Medicine

Volumn 133, Issue 3, 2000, Pages 165-175

  Lagergren, J ^a   Bergstrom, R ^a   Adami, H O ^a   Nyren, O ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; ATROPINE; BAMBUTEROL; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHLORDIAZEPOXIDE; CHOLINE THEOPHYLLINATE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DICYCLOVERINE; DIPHEMANIL METHYLSULFATE; DIPROPHYLLINE; EMEPRONIUM BROMIDE; FENOTEROL; GLYCERYL TRINITRATE; GLYCOPYRRONIUM BROMIDE; HEXOCYCLIUM METILSULFATE; HYOSCYAMINE; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; MEPENZOLATE; METHANTHELINE BROMIDE; PENTAERYTHRITYL TETRANITRATE; PIPENZOLATE BROMIDE; POLDINE METHYLSULFATE; PROPANTHELINE BROMIDE; PROXYPHYLLINE; SALBUTAMOL; SCOPOLAMINE BUTYL BROMIDE; TERBUTALINE; UNINDEXED DRUG;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CARDIA CARCINOMA; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

EID: 0034254576     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-3-200008010-00007     Document Type: Article

References (33)

1. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
2. The rising trend in esophageal adenocarcinoma and gastric cardia
3. Increasing incidence in both histological types of esophageal carcinomas among men in Sweden
4. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
5. Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992
6. Esophageal and gastric carcinoma in Norway 1958-1992: Incidence time trend variability according to morphological subtypes and organ subsites
7. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
8. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
9. Rising incidence rate of esophageal adenocarcinoma and use of pharmaceutical agents that relax the lower esophageal sphincter (United States)
10. Effects of 3-days' intake of a sustained-release preparation of the nitric oxide donor, isosorbide dinitrate, on oesophageal motility
11. The lower esophageal sphincter. Physiologic and clinical aspects
12. The effect of terbutaline sulfate, nitroglycerin, and aminophylline on lower esophageal sphincter pressure and radionuclide esophageal emptying in patients with achalasia
13. Effects of pirenzepine and atropine on basal lower esophageal pressure and gastric acid secretion in man: A placebo-controlled randomized study
14. Isosorbide dinitrate and nifedipine treatment of achalasia: A clinical, manometric and radionuclide evaluation
15. Oesophageal reflux and asthma
16. The effect of theophylline on the lower esophageal sphincter pressure
17. Inhibitory beta adrenergic receptors in the human distal esophagus
18. The effects of inhaled albuterol and oral theophylline on gastroesophageal reflux in patients with gastroesophageal reflux disease and obstructive lung disease
19. Mechanism of the lower esophageal sphincter relaxation. Action of prostaglandin E 1 and theophylline
20. Effect of an oral beta2-adrenergic agonist on lower esophageal sphincter pressure in normals and in patients with achalasia
21. Effect of theophylline on gastroesophageal reflux in normal adults
22. Effect of diazepam on the lower esophageal sphincter. A double-blind controlled study
23. Matching in case-control studies
24. Barrett's esophagus
25. Confounding by indication: An example of variation in the use of epidemiologic terminology
26. When can odds ratios mislead?
27. Measures of effect and association
28. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium-channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux
29. Precision and validity in epidemiologic studies
30. Proxy respondents in epidemiologic research
31. Validity of pharmacoepidemiology drug and diagnosis data
32. Gastroesophageal reflux and asthma
33. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans